Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10023573 Beta-lactamase inhibitor and process for preparing the same

Patent 10023573 was granted and assigned to Meiji Seika Pharma on July, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Meiji Seika Pharma

Current Assignee

Meiji Seika Pharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100235730

Patent Inventor Names

Takeshi Furuuchi0

Akihiro Morinaka0

Seiichi Inamura0

Takao Abe0

Yoshiaki Sakamaki0

Date of Patent

July 17, 2018

Patent Application Number

155832380

Date Filed

May 1, 2017

Patent Citations Received

‌

US Patent 11414417 Crystalline forms of diazabicyclooctane derivative and production process thereof

‌

US Patent 12103928 Processes for preparing a diazabicyclooctane compound

‌

US Patent 10604522 Processes for producing diazabicyclooctane compounds

Patent Primary Examiner

‌

Niloofar Rahmani

Patent abstract

A process for preparing a diazabicyclooctane compound represented by the following formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10023573 Beta-lactamase inhibitor and process for preparing the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API